Stony Brook University - Long Island Cancer Center — Stony Brook, New York

Stony Brook University - Long Island Cancer Center is a clinical research site located in Stony Brook, New York, United States 11794.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Stony Brook University - Long Island Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.

Sponsors: TransThera Sciences (Nanjing), Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stony Brook University - Long Island Cancer Center?

Stony Brook University - Long Island Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stony Brook University - Long Island Cancer Center conducted?

Stony Brook University - Long Island Cancer Center has 1 clinical trials on record. Their work covers Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.

Is Stony Brook University - Long Island Cancer Center accredited by Crixeo Health?

Stony Brook University - Long Island Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stony Brook University - Long Island Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.